Stock·NASDAQ·Financial Services
Nasdaq, Inc. (NDAQ)
- Market cap
- $52.26B
- P/E
- 27.74
- Dividend yield
- 1.24%
- Street target
- $108.50median of 18 analysts
- 52-week range
- $76.55 $101.79
The short version
Where NDAQ stands today, in four lines, and what CleaRank Financial AI makes of it.
NDAQ at a glance
Nasdaq, Inc. (NDAQ): Hold, 55/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($90.49 and $94.65).
- Earnings NDAQ beat estimates in 7 of its last 7 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $91.0M and bought $16.8M over the last 18 months.
- Valuation P/E of 27.7 against 16.5 for the Financial Services sector: a premium to peers (+68%).
Figures as of October 16, 2026.
CleaRank Financial AI
Nasdaq, Inc. (NDAQ) is currently trading at $93.50, below its 50-day simple moving average of $94.65, indicating some near-term weakness.
The company's recent earnings have shown consistent beats, with the latest quarter exceeding estimates by 9.18% and driving a 1.85% stock price increase. However, significant insider selling, totaling $91 million against $16.8 million in purchases, signals potential caution from management, despite a 'Heavy Sell Signal' verdict which is often driven by parent company divestitures or large institutional stake reductions. Financially, Nasdaq operates within the Financial Services sector, with its P/E ratio of 27.74 trading above the sector median of 16.5, and its price-to-sales ratio of 9.31 also exceeding the sector average of 3.8. The company's return on equity at 16.52% and profit margin of 35.04% are strong, outperforming sector averages. Despite these fundamental strengths, the current technical positioning and insider activity warrant a cautious approach.
Only on CleaRank
Figures we compute ourselves from NDAQ's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $93.50 is 1.2% below the 50-day simple moving average of $94.65.Price above its 200-day average ›
The price is 3.3% above the 200-day simple moving average of $90.49.50-day average above the 200-day ›
The 50-day average ($94.65) is 4.6% above the 200-day average ($90.49), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 67% of its 52-week range, between $76.55 and $101.79.
NDAQ share price
Pick a period: each tab shows how far NDAQ has moved over it, to the last close.
Today's trading
Where NDAQ sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 27.74 is 68.2% above the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 9.31 is 145.0% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $2.0B on revenue of $5.6B, a net margin of 35.0%.Beat estimates in most recent reports ›
NDAQ beat the EPS estimate in 7 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.24%, or $1.16 a share a year.
Key statistics
The headline figures for NDAQ.
As of October 16, 2026, NDAQ trades at $93.50, with a market value of $52.26B, a P/E ratio of 27.74 and a dividend yield of 1.24%.
What the numbers say
CleaRank Financial AI's reading of NDAQ's valuation, growth and risks.
Nasdaq, Inc. (NDAQ) exhibits strong profitability with a net profit margin of 35.04% and an operating margin of 49.33%, both significantly above sector averages.
Its return on equity stands at a healthy 16.52%. However, the company's valuation appears stretched when compared to its peers; its P/E ratio of 27.74 is considerably higher than the sector median of 16.5, and its price-to-sales ratio of 9.31 also exceeds the sector average of 3.8. The company's debt-to-equity ratio of 0.78 is in line with the sector average. While fundamental performance metrics are strong, the premium valuation suggests that current market price may not offer significant upside without continued strong growth or a sector re-rating. The company's revenue growth of 14.9% is also above the sector average of 11.7%.
NDAQ against the Financial Services sector
How NDAQ compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: NDAQ trades at a significant premium to sector peers (+68%), suggesting market expectations for superior growth or market position.
Return vs IAI: Since May 5, 2025, NDAQ has gained 19.6% against a gain of 23.2% for IAI.
Performance against IAI
NDAQ and the Financial Services sector fund over the same days.
Revenue and earnings
How much NDAQ sells, and how much of it becomes profit.
Revenue growth: Revenue grew 11.6% in FY2025 to $8.3B, from $7.4B a year earlier.
Profit margin: The net margin was 21.6% in FY2025, up from 15.1% the year before.
Profitable: NDAQ earned $1.8B in FY2025.
Earnings reality check
Did NDAQ beat what analysts expected, and how did the stock react?
Earnings record: NDAQ beat the analyst estimate in 7 of the last 7 quarters.
Market reaction: The stock fell in the first session after 3 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 23, 2026after close | $0.98 | $1.07 | +9.18% | +1.85% | +5.24% |
| Jan 29, 2026after close | $0.92 | $0.96 | +4.35% | -1.22% | -12.82% |
| Oct 21, 2025after close | $0.85 | $0.88 | +3.53% | -3.22% | -2.62% |
| Jul 24, 2025after close | $0.81 | $0.85 | +4.94% | +1.43% | +2.91% |
| Apr 24, 2025after close | $0.77 | $0.79 | +2.60% | +0.83% | +1.87% |
| Jan 29, 2025after close | $0.75 | $0.76 | +1.33% | +0.67% | +1.38% |
| Oct 24, 2024after close | $0.69 | $0.74 | +7.25% | -0.73% | -1.75% |
As of October 16, 2026, NDAQ has beaten the analyst EPS estimate in 7 of its last 7 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on July 23, 2026, came in 9.18% above the estimate and the stock moved +1.85% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 51.3, in neutral territory.RSI above 50 ›
An RSI of 51.3 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of NDAQ
The score, the reasoning behind it, and what could move the price next.
Nasdaq, Inc. is currently trading below its 50-day simple moving average of $94.65, suggesting a potential short-term downtrend, though it remains above its 200-day SMA of $90.49.
The 20-day exponential moving average at $93.01 is currently acting as support. The 14-day RSI is at 51.26, indicating neutral momentum, with no immediate signs of overbought or oversold conditions. Key support is identified around the $90.49 level (200-day SMA), while resistance lies near the $94.65 mark (50-day SMA). Volume on the latest trading day was 2.59 million, slightly below the average of 2.85 million, suggesting moderate trading interest. The overall chart structure indicates a stock consolidating, with a need to break above the 50-day SMA to regain bullish momentum.
Consistent Earnings Beats ›
Nasdaq, Inc. has a track record of exceeding analyst EPS estimates, most recently by 9.18% in Q3 2026, which has historically supported the stock price.
Source: Company Earnings ReportsStrong Revenue Growth ›
The company is projected to achieve 13.00% revenue growth in the current year, outpacing the sector average and indicating sustained business expansion.
Source: Wall Street EstimatesWall Street Analyst Coverage ›
With 18 analysts covering the stock, the consensus is generally positive ('Buy'), with a median price target of $108.50, suggesting potential upside.
Source: Analyst Reports
Significant Insider Selling ›
Insiders have sold over $91 million worth of stock in recent transactions, indicating potential caution or strategic portfolio adjustments by management and major holders.
Source: Insider Transaction FilingsPremium Valuation Metrics ›
Nasdaq's P/E ratio of 27.74 and P/S ratio of 9.31 are significantly higher than sector medians, increasing risk if growth falters.
Source: Financial Data Analysis
- A decisive move above the 50-day SMA ($94.65) would be a key technical signal to watch for a potential shift in short-term momentum.
Technical indicators
Momentum and trend for NDAQ, from its daily closes.
As of October 16, 2026, with NDAQ at $93.50, its 14-day RSI is 51.3 (neutral territory), its 50-day simple moving average is $94.65 and its 200-day is $90.49.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What NDAQ moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, NDAQ's 1-year correlation of daily returns is +0.52 with S&P 500 (SPY), +0.42 with Nasdaq 100 (QQQ), +0.30 with Bitcoin (BTC) and +0.04 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
14 of 18 analysts rate it a buy or strong buy, 3 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $108.50 is 16.0% above the price.More buy ratings than three months ago ›
14 of 18 rate it a buy now, against 14 of 17 three months ago.
NDAQ Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | Morgan Stanley | Maintains | Overweight |
| Oct 7, 2026 | Barclays | Maintains | Overweight |
| Oct 2, 2026 | Piper Sandler | Maintains | Overweight |
| Oct 2, 2026 | Wells Fargo | Initiates | Equal-Weight |
| Jul 24, 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform |
| Jul 24, 2026 | TD Cowen | Maintains | Buy |
As of October 16, 2026, 18 Wall Street analysts cover NDAQ: 14 rate it a buy or strong buy, 3 a hold and 1 a sell or strong sell. Their 12-month price targets range from $84.00 to $132.00, with a median of $108.50, 16.0% above the price of $93.50.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NDAQ trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NDAQ's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NDAQ tends to move, against the market and on its own.
The long record
NDAQ's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.39% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 30.8%, from November 2021 to May 2022, regained by August 2024.Most 1-year holds ended higher ›
82% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $49,457, against $42,525 in the S&P 500 (SPY).
NDAQ Drawdowns & Recovery
As of October 16, 2026, NDAQ's worst peak-to-trough fall over the last 10 years with dividends reinvested was -30.8% (November 2021 to May 2022); it regained that peak by August 2024, 27 months after the low, and 82% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NDAQ in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NDAQ beat the S&P 500 over this period: $49,457 against $42,525.
A $10,000 investment in NDAQ in October 2016 would be worth about $49,457 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NDAQ, and which have not.
Strongest month, July: an average of +7.61%, up in 9 of 10 years.
Weakest month, February: an average of -3.52%, up in 3 of 10 years.
This month, October: has averaged +0.65%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NDAQ's strongest calendar month has been July (average +7.61%, up in 9 of 10 years) and its weakest February (average -3.52%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NDAQ, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in NDAQ today could grow to about $24,454 by 2036 in the base case, with a 90th-percentile outcome near $66,810 and a 10th-percentile outcome around $8,951. The simulation models price only; at today's 1.24% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NDAQ Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $134 for NDAQ by 2030 in the base case, from $93.50 today (1.4x over 4 years). The 10th-percentile path ends near $70.81. These are outcomes of a Monte Carlo simulation run on NDAQ's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $74.41 | $102 | $141 | |
| 2028 | $71.33 | $112 | $175 | |
| 2029 | $70.51 | $122 | $212 | |
| 2030 | $70.81 | $134 | $252 | |
| 2031 | $71.83 | $146 | $298 |
Method: a lognormal simulation of NDAQ's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
NDAQ insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $16.8M on the open market and sold $91.0M.
As of October 16, 2026, NDAQ insiders reported 37 open-market sales worth $91.0M and 2 open-market purchases worth $16.8M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Jeremy Skule
Officer
|
Sell | 1.1K | $106.9K |
| Sep 10, 2026 | Jeremy Skule
Officer
|
Sell | 1.1K | $106.0K |
| Aug 10, 2026 | P C Nelson Griggs
Officer
|
Sell | 3.2K | $310.2K |
| Aug 10, 2026 | Jeremy Skule
Officer
|
Sell | 2.3K | $213.2K |
| Aug 7, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Sell | 6.0K | $573.3K |
| Aug 3, 2026 | Bryan Everard Smith
Officer
|
Sell | 1.6K | $147.9K |
| Jul 29, 2026 | P C Nelson Griggs
Officer
|
Sell | 11.0K | $1.1M |
| Jul 27, 2026 | P C Nelson Griggs
Officer
|
Sell | 17.8K | $1.7M |
| Jul 24, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Sell | 13.0K | $1.2M |
| Jul 1, 2026 | Bryan Everard Smith
Officer
|
Sell | 3.0K | $240.0K |
| Jun 11, 2026 | Bryan Everard Smith
Officer
|
Sell | 3.0K | $260.7K |
| Jun 10, 2026 | Melissa Arnoldi
Director
|
Grant | 4.3K | - |
| Jun 10, 2026 | Charlene T Begley
Director
|
Grant | 3.0K | - |
| Jun 10, 2026 | Essa Kazim
Director
|
Grant | 4.2K | - |
| Jun 10, 2026 | Thomas Archie Kloet
Director
|
Grant | 4.6K | - |
| Jun 10, 2026 | Kathryn A Koch
Director
|
Grant | 3.2K | - |
| Jun 10, 2026 | Paul Holden Spaht Jr
Director
|
Grant | 3.0K | - |
| Jun 10, 2026 | Michael R Splinter
Director
|
Grant | 5.2K | - |
| Jun 10, 2026 | Johan Torgeby
Director
|
Grant | 3.0K | - |
| Jun 10, 2026 | Toni Townes-Whitley
Director
|
Grant | 3.0K | - |
| Jun 10, 2026 | Jeffery William Yabuki
Director
|
Grant | 4.6K | - |
| Jun 10, 2026 | Alfred W Zollar
Director
|
Grant | 4.5K | - |
| May 18, 2026 | P C Nelson Griggs
Officer
|
Sell | 5.1K | $471.7K |
| Apr 28, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Sell | 7.7K | $700.2K |
| Apr 27, 2026 | Cohen Tal
Officer
|
Sell | 15.5K | $1.4M |
| Apr 24, 2026 | Michelle Lynn Daly
Officer
|
Sell | 1.3K | $117.5K |
| Apr 1, 2026 | Adena T Friedman
Chief Executive Officer
|
Sell | 113.6K | $9.7M |
| Apr 1, 2026 | Michelle Lynn Daly
Officer
|
Grant | 2.0K | - |
| Apr 1, 2026 | Adena T Friedman
Chief Executive Officer
|
Grant | 39.9K | - |
| Apr 1, 2026 | Adena T Friedman
Chief Executive Officer
|
Option | 113.6K | $2.5M |
| Apr 1, 2026 | P C Nelson Griggs
Officer
|
Grant | 11.7K | - |
| Apr 1, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Grant | 8.1K | - |
| Apr 1, 2026 | Jeremy Skule
Officer
|
Grant | 7.6K | - |
| Apr 1, 2026 | Bryan Everard Smith
Officer
|
Grant | 7.0K | - |
| Apr 1, 2026 | Cohen Tal
Officer
|
Grant | 15.3K | - |
| Apr 1, 2026 | Sarah Youngwood
Chief Financial Officer
|
Grant | 15.3K | - |
| Apr 1, 2026 | John Zecca
Officer
|
Grant | 7.3K | - |
| Mar 11, 2026 | Adena T Friedman
Chief Executive Officer
|
Grant | 113.6K | - |
| Mar 6, 2026 | Adena T Friedman
Chief Executive Officer
|
Sell | 92.8K | $8.4M |
| Mar 6, 2026 | Adena T Friedman
Chief Executive Officer
|
Option | 92.8K | $2.1M |
| Mar 2, 2026 | Bryan Everard Smith
Officer
|
Sell | 6.0K | $523.4K |
| Feb 19, 2026 | Michelle Lynn Daly
Officer
|
Sell | 4.3K | $352.9K |
| Feb 17, 2026 | Johan Torgeby
Director
|
Buy | 12.0K | $958.3K |
| Feb 13, 2026 | Ab Investor
Beneficial Owner of more than 10% of a Class of Security
|
Buy | 200.0K | $15.8M |
| Feb 12, 2026 | Adena T Friedman
Chief Executive Officer
|
Grant | 270.2K | - |
| Feb 11, 2026 | Michelle Lynn Daly
Officer
|
Grant | 8.7K | - |
| Feb 11, 2026 | P C Nelson Griggs
Officer
|
Grant | 56.8K | - |
| Feb 11, 2026 | Bradley J. Peterson
Chief Technology Officer
|
Grant | 53.6K | - |
| Feb 11, 2026 | Jeremy Skule
Officer
|
Grant | 34.4K | - |
| Feb 11, 2026 | Bryan Everard Smith
Officer
|
Grant | 29.1K | - |
| Feb 11, 2026 | Cohen Tal
Officer
|
Grant | 56.8K | - |
| Feb 11, 2026 | John Zecca
Officer
|
Grant | 32.6K | - |
| Feb 2, 2026 | Adena T Friedman
Chief Executive Officer
|
Sell | 300.0K | $29.1M |
| Feb 2, 2026 | Adena T Friedman
Chief Executive Officer
|
Option | 300.0K | $6.7M |
| Jan 30, 2026 | Michael R Splinter
Director
|
Grant | 4.7K | - |
| Jan 6, 2026 | John Zecca
Officer
|
Sell | 4.5K | $450.0K |
| Jan 2, 2026 | Adena T Friedman
Chief Executive Officer
|
Sell | 300.0K | $28.9M |
| Jan 2, 2026 | Adena T Friedman
Chief Executive Officer
|
Option | 300.0K | $6.7M |
| Dec 1, 2025 | Bryan Everard Smith
Officer
|
Sell | 4.6K | $419.6K |
| Dec 1, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $190.7K |
| Nov 3, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $179.8K |
| Oct 1, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $185.7K |
| Sep 2, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $196.2K |
| Aug 4, 2025 | Charlene T Begley
Director
|
Sell | 3.0K | $289.8K |
| Aug 1, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $201.0K |
| Jul 25, 2025 | Michelle Lynn Daly
Officer
|
Sell | 8.7K | $812.2K |
| Jul 2, 2025 | Bradley J. Peterson
Chief Technology Officer
|
Sell | 11.5K | $1.0M |
| Jul 1, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $187.7K |
| Jun 11, 2025 | Melissa Arnoldi
Director
|
Grant | 4.3K | - |
| Jun 11, 2025 | Charlene T Begley
Director
|
Grant | 3.0K | - |
| Jun 11, 2025 | Essa Kazim
Director
|
Grant | 4.1K | - |
| Jun 11, 2025 | Thomas Archie Kloet
Director
|
Grant | 4.5K | - |
| Jun 11, 2025 | Kathryn A Koch
Director
|
Grant | 3.2K | - |
| Jun 11, 2025 | Paul Holden Spaht Jr
Director
|
Grant | 3.0K | - |
| Jun 11, 2025 | Michael R Splinter
Director
|
Grant | 5.2K | - |
| Jun 11, 2025 | Johan Torgeby
Director
|
Grant | 3.0K | - |
| Jun 11, 2025 | Toni Townes-Whitley
Director
|
Grant | 3.0K | - |
| Jun 11, 2025 | Jeffery William Yabuki
Director
|
Grant | 4.6K | - |
| Jun 11, 2025 | Alfred W Zollar
Director
|
Grant | 4.5K | - |
| Jun 6, 2025 | P C Nelson Griggs
Officer
|
Sell | 4.0K | $340.9K |
| Jun 6, 2025 | Jeremy Skule
Officer
|
Sell | 2.1K | $178.8K |
| Jun 4, 2025 | Paul Holden Spaht Jr
Director
|
Grant | 447.2K | - |
| Jun 2, 2025 | Jeremy Skule
Officer
|
Sell | 1.1K | $87.7K |
| May 27, 2025 | P C Nelson Griggs
Officer
|
Sell | 8.0K | $664.2K |
| May 12, 2025 | Jeremy Skule
Officer
|
Sell | 1.1K | $85.8K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.